NOTIFICATION: MiR-375-3p/YWHAZ/β-catenin Axis Regulates Migration, Invasion, EMT in Gastric Cancer Cells

IF 2.9 4区医学 Q2 Medicine

Clinical and Experimental Pharmacology and Physiology Pub Date : 2025-04-29 DOI:10.1111/1440-1681.70045

{"title":"NOTIFICATION: MiR-375-3p/YWHAZ/β-catenin Axis Regulates Migration, Invasion, EMT in Gastric Cancer Cells","authors":"","doi":"10.1111/1440-1681.70045","DOIUrl":null,"url":null,"abstract":"\n NOTIFICATION: F. Guo, Y. Gao, G. Sui, D. Jiao, L. Sun, Q. Fu, and C. Jin, “ MiR-375-3p/YWHAZ/β-catenin Axis Regulates Migration, Invasion, EMT in Gastric Cancer Cells,” Clinical and Experimental Pharmacology and Physiology 46, no. 2 (2019): 144–152, https://doi.org/10.1111/1440-1681.13047.\n This notification is for the above article, published online on 24 October 2018 in Wiley Online Library (wileyonlinelibrary.com), and has been issued by agreement between the journal Editor-in-Chief, Yang Yang; and John Wiley & Sons Australia Ltd. This notification has been issued in response to concerns raised by third parties [1]. The article mentions a non-verifiable cell line identifier, “MGC-823” in relation to Figure 1C. Within the figure, the cell line identifier is spelled “MGC-803”, which describes a verified cell line (RRID: CVCL_5334). As the authors could not be reached to clarify this discrepancy, the journal has decided to publish this notification to inform and alert readers.","PeriodicalId":50684,"journal":{"name":"Clinical and Experimental Pharmacology and Physiology","volume":"52 6","pages":""},"PeriodicalIF":2.9000,"publicationDate":"2025-04-29","publicationTypes":"Journal Article","fieldsOfStudy":null,"isOpenAccess":false,"openAccessPdf":"https://onlinelibrary.wiley.com/doi/epdf/10.1111/1440-1681.70045","citationCount":"0","resultStr":null,"platform":"Semanticscholar","paperid":null,"PeriodicalName":"Clinical and Experimental Pharmacology and Physiology","FirstCategoryId":"3","ListUrlMain":"https://onlinelibrary.wiley.com/doi/10.1111/1440-1681.70045","RegionNum":4,"RegionCategory":"医学","ArticlePicture":[],"TitleCN":null,"AbstractTextCN":null,"PMCID":null,"EPubDate":"","PubModel":"","JCR":"Q2","JCRName":"Medicine","Score":null,"Total":0}

引用次数: 0

Abstract

NOTIFICATION: F. Guo, Y. Gao, G. Sui, D. Jiao, L. Sun, Q. Fu, and C. Jin, “ MiR-375-3p/YWHAZ/β-catenin Axis Regulates Migration, Invasion, EMT in Gastric Cancer Cells,” Clinical and Experimental Pharmacology and Physiology 46, no. 2 (2019): 144–152, https://doi.org/10.1111/1440-1681.13047.

This notification is for the above article, published online on 24 October 2018 in Wiley Online Library (wileyonlinelibrary.com), and has been issued by agreement between the journal Editor-in-Chief, Yang Yang; and John Wiley & Sons Australia Ltd. This notification has been issued in response to concerns raised by third parties [1]. The article mentions a non-verifiable cell line identifier, “MGC-823” in relation to Figure 1C. Within the figure, the cell line identifier is spelled “MGC-803”, which describes a verified cell line (RRID: CVCL_5334). As the authors could not be reached to clarify this discrepancy, the journal has decided to publish this notification to inform and alert readers.

查看原文本刊更多论文

通知：MiR-375-3p/YWHAZ/β-catenin轴调节胃癌细胞的迁移、侵袭和EMT

通报：郭峰，高勇，隋国光，焦东东，孙丽丽，付强，金超，“MiR-375-3p/YWHAZ/β-catenin轴调控胃癌细胞的迁移、侵袭和EMT”，《临床与实验药理学》，第46期，no。2 (2019): 144-152, https://doi.org/10.1111/1440-1681.13047。上述文章已于2018年10月24日在线发表在Wiley在线图书馆（wileyonlinelibrary.com）上，经期刊主编杨洋同意发布。约翰·威利&；澳大利亚之子有限公司本通知是针对第三方b[1]提出的担忧而发布的。文章提到了与图1C相关的不可验证的细胞系标识符“MGC-823”。在图中，细胞系标识符拼写为“MGC-803”，它描述了经过验证的细胞系（RRID: CVCL_5334）。由于无法联系到作者澄清这一差异，该杂志决定发表这一通知，以通知和提醒读者。

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文求助全文

来源期刊

Clinical and Experimental Pharmacology and Physiology 医学-生理学

CiteScore

6.20

自引率

0.00%

发文量

128

审稿时长

6 months

期刊介绍： Clinical and Experimental Pharmacology and Physiology is an international journal founded in 1974 by Mike Rand, Austin Doyle, John Coghlan and Paul Korner. Our focus is new frontiers in physiology and pharmacology, emphasizing the translation of basic research to clinical practice. We publish original articles, invited reviews and our exciting, cutting-edge Frontiers-in-Research series’.